(Q24235068)

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Adding fuel to the fire: GM-CSF for active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Sargramostim in patients with Crohn's disease: results of a phase 1-2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Meta-analysis: remission and response from control arms of randomized trials of biological therapies for active luminal Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Methotrexate for induction of remission in refractory Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Traditional corticosteroids for induction of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Aminosalicylates for induction of remission or response in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Natalizumab for induction of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Certolizumab pegol for the treatment of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Budesonide for induction of remission in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Treatment of fistulas with granulocyte colony-stimulating factor in a patient with Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008538.PUB2